{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:11:34Z","timestamp":1759842694378,"version":"build-2065373602"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-025-00786-w","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:30:39Z","timestamp":1759840239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence, outcomes, and risk factors of Heparin-induced thrombocytopenia in patients undergoing primary and revision knee arthroplasty"],"prefix":"10.1186","volume":"23","author":[{"given":"TingJie","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MingCong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"QinFeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SiJia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YuHang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XuanJian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"issue":"10414","key":"786_CR1","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/S0140-6736(23)01726-9","volume":"402","author":"M Kloppenburg","year":"2023","unstructured":"Kloppenburg M. Inflammation is a relevant treatment target in osteoarthritis[J]. Lancet. 2023;402(10414):1725\u20136.","journal-title":"Lancet"},{"key":"786_CR2","doi-asserted-by":"crossref","unstructured":"Falck-Ytter Y, Francis CW, Johanson NA et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis: American college of chest physicians Evidence-Based clinical practice Guidelines[J]. Chest, 2012, 141(2): e278S-e325S.","DOI":"10.1378\/chest.11-2404"},{"issue":"2","key":"786_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/EJA.0000000000000728","volume":"35","author":"JY Jenny","year":"2018","unstructured":"Jenny JY, Pabinger I, Samama CM. European guidelines on perioperative venous thromboembolism prophylaxis: aspirin[J]. Eur J Anesthesiology| EJA. 2018;35(2):123\u20139.","journal-title":"Eur J Anesthesiology| EJA"},{"issue":"9","key":"786_CR4","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s00264-022-05496-w","volume":"46","author":"SS Na","year":"2022","unstructured":"Na SS, Kim DH, Choi BC, et al. Incidence, characteristics, and risk factors for venousthromboembolism in shoulder arthroplasty\u2014a systematic review[J]. Int Orthop. 2022;46(9):2081\u20138.","journal-title":"Int Orthop"},{"issue":"1","key":"786_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3928\/01477447-20201119-01","volume":"44","author":"AZ Chen","year":"2021","unstructured":"Chen AZ, Gu A, Wei C, et al. Increase in operative time is associated with postoperative complications in revision total knee arthroplasty. Orthopedics. 2021;44(1):18\u201322.","journal-title":"Orthopedics"},{"issue":"16","key":"786_CR6","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1182\/blood-2013-10-533083","volume":"123","author":"TE Warkentin","year":"2014","unstructured":"Warkentin TE, Sheppard JAI. Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin. Blood. 2014;123(16):2485\u201393.","journal-title":"Blood"},{"key":"786_CR7","doi-asserted-by":"crossref","unstructured":"Camoin-Jau L, Mariotti A, Suchon P, et al. La thrombop\u00e9nie induite par h\u00e9parine: mise aupoint[J]. Volume 43. La Revue de M\u00e9decine Interne; 2022. pp. 18\u201325. 1.","DOI":"10.1016\/j.revmed.2021.08.011"},{"issue":"21","key":"786_CR8","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/j.jacc.2016.02.073","volume":"67","author":"BS Salter","year":"2016","unstructured":"Salter BS, Weiner MM, Trinh MA, et al. Heparin-induced thrombocytopenia: acomprehensive clinical review[J]. J Am Coll Cardiol. 2016;67(21):2519\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"786_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/nep.14138","volume":"28","author":"C Ghimire","year":"2023","unstructured":"Ghimire C, Baral N, Vinjam T, et al. In-hospital mortality of heparin-induced thrombocytopenia in end-stage kidney disease. A retrospective national population-based cohort study. Nephrology. 2023;28(3):168\u201374.","journal-title":"Nephrology"},{"issue":"5","key":"786_CR10","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","volume":"154","author":"GYH Lip","year":"2018","unstructured":"Lip GYH, Banerjee A, Boriani G, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report[J]. Chest. 2018;154(5):1121\u2013201.","journal-title":"Chest"},{"key":"786_CR11","doi-asserted-by":"publisher","first-page":"107602962110429","DOI":"10.1177\/10760296211042938","volume":"27","author":"Y Chen","year":"2021","unstructured":"Chen Y, Wang J, Shi Z, et al. Incidence, outcomes and risk factors for heparin-induced thrombocytopenia after total joint arthroplasty: a National inpatient sample database study[J]. Clin Appl Thromb Hemost. 2021;27:10760296211042938.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"786_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/bjh.12242","volume":"161","author":"JD Craik","year":"2013","unstructured":"Craik JD, Cobb AG. Heparin-induced thrombocytopenia following hip and knee arthroplasty. Br J Haematol. 2013;161(2):255\u201361.","journal-title":"Br J Haematol"},{"key":"786_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jss.2020.08.002","volume":"258","author":"OA Olufajo","year":"2021","unstructured":"Olufajo OA, Wilson A, Zeineddin A, et al. Coronary artery bypass grafting among older adults: patterns, outcomes, and trends. J Surg Res. 2021;258:345\u201351.","journal-title":"J Surg Res"},{"issue":"3","key":"786_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/1556984520909799","volume":"15","author":"D Zapata","year":"2020","unstructured":"Zapata D, Binongo J, Lasanajak Y, et al. Heparin-induced thrombocytopenia in patients undergoing valvular and aortic surgery: a modern assessment of risk. Innovations. 2020;15(3):229\u201334.","journal-title":"Innovations"},{"issue":"4","key":"786_CR15","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1097\/PRS.0000000000004255","volume":"141","author":"DL Colen","year":"2018","unstructured":"Colen DL, Carney MJ, Shubinets V, et al. Soft-tissue reconstruction of the complicated knee arthroplasty: principles and predictors of salvage[J]. Plast Reconstr Surg. 2018;141(4):1040\u20138.","journal-title":"Plast Reconstr Surg"},{"key":"786_CR16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.knee.2020.09.006","volume":"28","author":"R Morgan-Jones","year":"2021","unstructured":"Morgan-Jones R. Infected total knee replacement: how i do a one-stage revision. Knee. 2021;28:422\u20137.","journal-title":"Knee"},{"issue":"1","key":"786_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/chd.12557","volume":"13","author":"U Pollak","year":"2018","unstructured":"Pollak U, Mishaly D, Kenet G, et al. Heparin-induced thrombocytopenia complicating children after the Fontan procedure: single\u2010center experience and review of the literature. Congenit Heart Dis. 2018;13(1):16\u201325.","journal-title":"Congenit Heart Dis"},{"issue":"2","key":"786_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11060-020-03395-x","volume":"146","author":"EM Luther","year":"2020","unstructured":"Luther EM, McCarthy D, Berry KM, et al. Hospital teaching status associated with reduced inpatient mortality and perioperative complications in surgical neuro-oncology. J Neurooncol. 2020;146(2):389\u201396.","journal-title":"J Neurooncol"},{"issue":"7","key":"786_CR19","doi-asserted-by":"publisher","first-page":"S289","DOI":"10.1016\/j.arth.2023.04.022","volume":"38","author":"S Coombs","year":"2023","unstructured":"Coombs S, Oakley CT, Buehring W, et al. Hospital teaching status and Patient-Reported outcomes following primary total hip arthroplasty: an American joint replacement registry Study[J]. J Arthroplast. 2023;38(7):S289\u201393.","journal-title":"J Arthroplast"},{"issue":"1","key":"786_CR20","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.amepre.2016.09.004","volume":"52","author":"GR Oates","year":"2017","unstructured":"Oates GR, Jackson BE, Partridge EE, et al. Sociodemographic patterns of chronic disease: how the mid-south region compares to the rest of the country[J]. Am J Prev Med. 2017;52(1):S31\u20139.","journal-title":"Am J Prev Med"},{"key":"786_CR21","first-page":"923","volume":"59","author":"JF Viles-Gonzalez","year":"2012","unstructured":"Viles-Gonzalez JF, Reddy VY. New oral anticoagulants: good but not good Enough![J]. Cardiol. 2012;59:923\u20139.","journal-title":"Cardiol"},{"issue":"1","key":"786_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00408-016-9961-5","volume":"195","author":"DGS Tannus-Silva","year":"2017","unstructured":"Tannus-Silva DGS, Rabahi MF. State of the art review of the right ventricle in COPD patients: it is time to look closer. Lung. 2017;195(1):9\u201317.","journal-title":"Lung"},{"issue":"2","key":"786_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.athoracsur.2020.10.046","volume":"112","author":"JA Brown","year":"2021","unstructured":"Brown JA, Aranda-Michel E, Kilic A, et al. Outcomes with heparin-induced thrombocytopenia after cardiac surgery[J]. Ann Thorac Surg. 2021;112(2):487\u201393.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"786_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3109\/08880018.2011.570417","volume":"28","author":"ZK Yildirim","year":"2011","unstructured":"Yildirim ZK, Sepetcigil O, Karacan M, et al. Resolution of pulmonary hypertension with low-molecular-weight heparin, steroid, and Prostacyclin analog therapy: could it be early-phase pulmonary veno-occlusive disease?[J]. Pediatr Hematol Oncol. 2011;28(6):529\u201334.","journal-title":"Pediatr Hematol Oncol"},{"issue":"01","key":"786_CR25","doi-asserted-by":"publisher","first-page":"059","DOI":"10.1055\/a-1336-6116","volume":"41","author":"L Ranta","year":"2021","unstructured":"Ranta L, Scala E. GTH 2021 state of the art\u2014cardiac surgery: the perioperative management of heparin-induced thrombocytopenia in cardiac surgery. Hamostaseologie. 2021;41(01):059\u201362.","journal-title":"Hamostaseologie"},{"issue":"1","key":"786_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.athoracsur.2020.09.033","volume":"112","author":"JR Crow","year":"2021","unstructured":"Crow JR, Nam L, Chasler JE, et al. Association of heparin dose, route, timing, and duration with heparin-induced thrombocytopenia. Ann Thorac Surg. 2021;112(1):32\u20137.","journal-title":"Ann Thorac Surg"},{"key":"786_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X14533945","volume":"2","author":"W Wu","year":"2014","unstructured":"Wu W, Merriman K, Nabaah A, et al. Heparin-induced thrombocytopenia among patients of a comprehensive cancer center. SAGE Open Med Case Rep. 2014;2:2050313X14533945.","journal-title":"SAGE Open Med Case Rep"},{"issue":"1","key":"786_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1001\/archinte.164.1.66","volume":"164","author":"AF Srinivasan","year":"2004","unstructured":"Srinivasan AF, Rice L, Bartholomew JR, et al. Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia[J]. Arch Intern Med. 2004;164(1):66\u201370.","journal-title":"Arch Intern Med"},{"key":"786_CR29","doi-asserted-by":"crossref","unstructured":"Jang Khan NA, Farooqi A, Alsharedi M. A rare case of extensive cerebral venous sinus thrombosis complicated by Heparin-Induced Thrombocytopenia[J]. Volume 2022. Case Reports in Hematology; 2022. p. 7845786. 1.","DOI":"10.1155\/2022\/7845786"},{"issue":"03","key":"786_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.bjid.2014.01.003","volume":"18","author":"K Honorato-Sampaio","year":"2014","unstructured":"Honorato-Sampaio K, Guedes ACM, Lima V, L A N, et al. Bacterial biofilm in chronic venous ulcer[J]. Brazilian J Infect Dis. 2014;18(03):350\u20131.","journal-title":"Brazilian J Infect Dis"},{"issue":"3","key":"786_CR31","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40801-021-00258-3","volume":"8","author":"IY Shao","year":"2021","unstructured":"Shao IY, Claxton JNS, Lutsey PL, et al. Association of type of antidepressant initiation with bleeding risk in atrial fibrillation patients taking oral anticoagulants[J]. Drugs-Real World Outcomes. 2021;8(3):383\u201391.","journal-title":"Drugs-Real World Outcomes"},{"issue":"2","key":"786_CR32","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/cam4.4976","volume":"12","author":"S Hu","year":"2023","unstructured":"Hu S, Baraghoshi D, Chang CP, et al. Mental health disorders among ovarian cancer survivors in a population-based cohort. Cancer Med. 2023;12(2):1801\u201312.","journal-title":"Cancer Med"},{"issue":"1","key":"786_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1053\/j.jvca.2013.07.021","volume":"28","author":"M Seigerman","year":"2014","unstructured":"Seigerman M, Cavallaro P, Itagaki S, et al. Incidence and outcomes of heparin-induced thrombocytopenia in patients undergoing cardiac surgery in North America: an analysis of the nationwide inpatient sample. J Cardiothorac Vasc Anesth. 2014;28(1):98\u2013102.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"786_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2023.102270","volume":"62","author":"S Kondo","year":"2023","unstructured":"Kondo S, Inoue T, Saito T, et al. Impact of postoperative physical activity on the development of pneumonia in the subacute phase after esophagectomy in patients with esophageal cancer: a retrospective cohort study. Eur J Oncol Nurs. 2023;62:102270.","journal-title":"Eur J Oncol Nurs"},{"key":"786_CR35","doi-asserted-by":"crossref","unstructured":"McIsaac DI, Hamilton GM, Abdulla K, et al. Validation of new ICD-10-based patient safety indicators for identification of in-hospital complications in surgical patients: a study of diagnostic accuracy[J]. Volume 29. BMJ quality & safety; 2020. pp. 209\u201316. 3.","DOI":"10.1136\/bmjqs-2018-008852"},{"issue":"1","key":"786_CR36","first-page":"74","volume":"5","author":"KG Fischer","year":"2001","unstructured":"Fischer KG. Mechanism and clinical presentation of heparin-induced thrombocytopenia. Hemodial Int. 2001;5(1):74\u201380.","journal-title":"Hemodial Int"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00786-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-025-00786-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00786-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:30:43Z","timestamp":1759840243000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-025-00786-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["786"],"URL":"https:\/\/doi.org\/10.1186\/s12959-025-00786-w","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animalsperformed by any of the authors. Administrative permissions were required to access the raw data employed in this study, and the affiliation of co-authorhas already granted permission from the Agency for Healthcare Research and Quality(AHRQ)to access Healthcare Cost and Utilization Project (HUCP)Nationwide Databases. However, our observational study was deemed exempt bythe Ethics Committee of Nanfang Hospital of Southern Medical University forusing deidentified publicly available data. Besides, the data collected in ourstudy were unnecessary to be anonymized before its use. All methods werecarried out following relevant guidelines and regulations..","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}